Inhibition of tumor growth and angiogenesis by a lysophosphatidic acid antagonist in an engineered three-dimensional lung cancer xenograft model.
about
Autotaxin-LPA receptor axis in the pathogenesis of lung diseasesA metabolically-stabilized phosphonate analog of lysophosphatidic acid attenuates collagen-induced arthritisDiagnostic and prognostic significance of lysophosphatidic acid in malignant pleural effusions.Lysophosphatidic acid enhanced the angiogenic capability of human chondrocytes by regulating Gi/NF-kB-dependent angiogenic factor expressionDipalmitoylphosphatidic acid inhibits tumor growth in triple-negative breast cancerGPCRs and cancerStimulation of in vivo angiogenesis by in situ crosslinked, dual growth factor-loaded, glycosaminoglycan hydrogels.Bioactive lipids, LPC and LPA, are novel prometastatic factors and their tissue levels increase in response to radio/chemotherapyCARMA3: A novel scaffold protein in regulation of NF-κB activation and diseasesHypoxia and free radicals: role in tumor progression and the use of engineering-based platforms to address these relationships.3D tissue-engineered model of Ewing's sarcomaEffects of lysophospholipids on tumor microenvironmentVinyl sulfone analogs of lysophosphatidylcholine irreversibly inhibit autotaxin and prevent angiogenesis in melanoma.Expression of lysophosphatidic acid receptors and local invasiveness and metastasis in Chinese pancreatic cancers.Establishment and characterization of intraperitoneal xenograft models by co-injection of human tumor cells and extracellular matrix gelLysophosphatidic acid (LPA) and its receptors: role in airway inflammation and remodeling.Autotaxin, a lysophospholipase D with pleomorphic effects in oncogenesis and cancer progressionEngineering approaches for investigating tumor angiogenesis: exploiting the role of the extracellular matrixControlling cancer through the autotaxin-lysophosphatidic acid receptor axis.The role of LPA and YAP signaling in long-term migration of human ovarian cancer cells.Autotaxin induces lung epithelial cell migration through lysoPLD activity-dependent and -independent pathways.Membrane phospholipids, EML4-ALK, and Hsp90 as novel targets in lung cancer treatment.A new perspective of vasculogenic mimicry: EMT and cancer stem cells (Review).Evaluating dual activity LPA receptor pan-antagonist/autotaxin inhibitors as anti-cancer agents in vivo using engineered human tumorsMultiphasic construct studied in an ectopic osteochondral defect model.Hyaluronic acid-based clinical biomaterials derived for cell and molecule delivery in regenerative medicine.Lysophosphatidic acid (LPA) and endothelial differentiation gene (Edg) receptors in human pancreatic cancer.Lysophosphatidic acid (LPA) signalling in cell migration and cancer invasion: a focussed review and analysis of LPA receptor gene expression on the basis of more than 1700 cancer microarrays.New strategies for the treatment of ovarian cancer.Promising pharmacological directions in the world of lysophosphatidic Acid signaling.Bioprinting Cellularized Constructs Using a Tissue-specific Hydrogel Bioink.Attenuation of LPS-induced cyclooxygenase-2 and inducible NO synthase expression by lysophosphatidic acid in macrophages.Orally active lysophosphatidic acid receptor antagonist attenuates pancreatic cancer invasion and metastasis in vivo.Lysophosphatidic acid receptor 2/3-mediated IL-8-dependent angiogenesis in cervical cancer cells.Evaluation of tumor formation of three bladder cancer cell lines in nude mice.Morinda citrifolia edible leaf extract enhanced immune response against lung cancer.G Protein-Coupled Receptors at the Crossroad between Physiologic and Pathologic Angiogenesis: Old Paradigms and Emerging Concepts.Autotaxin-Lysophosphatidic Acid: From Inflammation to Cancer Development.Necessity of lysophosphatidic acid receptor 1 for development of arthritis.
P2860
Q26862679-70B3277B-00E8-47F3-B1CD-EDBA4744FC41Q28534911-B7E506A1-073E-4DFB-9171-BCBD7A5890F4Q33585979-D028AE30-D4C1-4DDD-8460-BCF296B1E80EQ33689905-93E653B0-6EBE-4210-9CA0-918A8D807AE6Q33703293-0023273C-D59D-4739-BCA7-57A4391C62A2Q33828719-EAF38080-AC69-4825-AA39-63839DD33BDDQ33854827-6A843758-DD15-4949-ACC9-784FFF4B4AF8Q34518525-414F0334-69A1-49A6-AFC8-1BF3F073701FQ34878582-C1E18AA4-C511-46B9-B952-6EE7252E81BCQ35117865-CBFC6FFF-F65B-40EA-AFA3-24EBA781780FQ35428655-F1B863A5-7F45-4EBD-9D83-86325CC13062Q35603140-AFFC364E-60F8-47DC-B747-3DE056868392Q36011319-919178A9-F777-40F3-A21F-C40D585FDDECQ36145321-82CDF930-8B36-4658-812D-937D129CAC35Q36336223-13DA750F-F4DC-4543-9D36-93694C78DD22Q36377195-11A30275-B2FD-4AA1-9E0F-1D95D06F885BQ36399256-AED596C7-2221-4F56-959B-04D0EDFF2620Q36442261-D557F99D-BFB9-4594-901E-14423D66E77AQ36664243-0A66049E-968A-49FD-8F5D-4826F5857231Q36847992-22E4D803-10DA-4149-88FE-DCB7D03C2230Q36907755-58CDB0DD-7F34-4BE2-9DF4-E8A0358A0CADQ37031569-EA1892A8-0797-43CA-A6E1-C51E4BFD5497Q37269588-588AE3B8-EFA6-47E3-BFEB-4F262EF96F56Q37372468-B4B8A21B-B60F-4C68-BF0E-82C9F628C3B8Q37735400-4D1DB0B2-5D98-4AAB-B023-6723AE8924B5Q37868075-E9552695-6CBC-4D7E-BD9A-D1F89F0E7B1BQ37899821-22566487-67E0-4526-9A44-061E75A6D46EQ38101074-753E0B5C-8242-4545-A841-56FED57CE3CAQ38180769-9023BD74-DC34-406D-8E27-781BBCC94E02Q38320338-B2C9D110-ACAA-4A68-99DB-0D422EAA548AQ38868772-9DC78AD0-54C7-4D58-A749-6FBE61339FA0Q38898326-72374E91-E228-4220-91FE-845E033D55B3Q39393931-F87E6BE3-1F03-4910-8CF3-3F6352F4056DQ39464516-EB448993-B742-4529-90D6-C366F272A08BQ39555946-77EA18B3-2C72-4CBD-A37E-CD32459CEC5AQ40977881-82B7A141-6095-479D-9F3F-EA1EF735E5FBQ47174627-AD82706D-44A5-4E21-B086-BEE7D4493EDFQ50074055-82F28225-21FE-49F3-96AD-BF69A46ECE60Q50999735-D4C8E914-D5B1-4A77-AB59-E41E252FB98E
P2860
Inhibition of tumor growth and angiogenesis by a lysophosphatidic acid antagonist in an engineered three-dimensional lung cancer xenograft model.
description
2010 nî lūn-bûn
@nan
2010 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Inhibition of tumor growth and ...... l lung cancer xenograft model.
@ast
Inhibition of tumor growth and ...... l lung cancer xenograft model.
@en
type
label
Inhibition of tumor growth and ...... l lung cancer xenograft model.
@ast
Inhibition of tumor growth and ...... l lung cancer xenograft model.
@en
prefLabel
Inhibition of tumor growth and ...... l lung cancer xenograft model.
@ast
Inhibition of tumor growth and ...... l lung cancer xenograft model.
@en
P2860
P356
P1433
P1476
Inhibition of tumor growth and ...... l lung cancer xenograft model.
@en
P2093
Glenn D Prestwich
P2860
P304
P356
10.1002/CNCR.24907
P407
P577
2010-04-01T00:00:00Z